lomustine has been researched along with cytarabine in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (44.05) | 18.7374 |
1990's | 13 (15.48) | 18.2507 |
2000's | 12 (14.29) | 29.6817 |
2010's | 18 (21.43) | 24.3611 |
2020's | 4 (4.76) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Comelli, A; Massimo, L | 1 |
Salem, PA | 1 |
Murphy, GP; Sufrin, G | 1 |
Barranco, SC; Gee, EL; Haenelt, BR | 1 |
Golbey, RB | 1 |
Bloustein, PA; Silverberg, SG; Waddell, WR | 1 |
Bhuyan, BK; Day, KJ; Fraser, TJ | 1 |
Moertel, CG | 1 |
Burgert, EO; Cuttner, J; Degnan, T; Del Duca, V; Falkson, G; Freeman, A; Hakami, N; Holland, J; Koch, K; Kung, FH; Lanzkowsky, P; Leone, LA; Nawabi, IU; Nythan, WL; Pajak, TF; Patterson, RB; Pluess, H; Ruymann, F | 1 |
Albert, ED; Bender-Gotze, C; Grosse-Wilde, H; Kolb, HJ; Lieven, HV; Thiel, E; Wundisch, GF | 1 |
Cavalier, J; David, R; Duhamel, G; Gorin, NC; Hirsch Marie, F; Jullien, AM; Leblanc, G; Muller, JY; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J | 1 |
Marsh, JC | 1 |
Bluming, AZ; Magrath, IT; Ziegler, JL | 1 |
Posner, JB; Shapiro, WR; Ushio, Y | 1 |
Sauter, C | 1 |
Bernard, J; Boiron, M; Chastang, CL; Gemon-Auclerc, MF; Izrael, V; Jacyuillat, CI; Weil, M | 1 |
Brunner, K; Dear, KB; Haurani, F; Holland, JF; Karanas, A; Silver, RT; Weil, M | 1 |
Costello, C; McCarthy, D; Mir, N; Nadir, F; Rule, S; Samson, D; Taylor, J | 1 |
Douay, L; Fenaux, P; Fouillard, L; Gorin, NC; Isnard, F; Jouet, JP; Laporte, JP; Lopez, M; Morel, P; Walter, MP | 1 |
Hagenbeek, A; Löwenberg, B; Michiels, J; Ruit, JB; Sizoo, W; Verhoef, GE; Wielenga, JJ | 1 |
Barrett, AJ; McCarthy, DM; Slater, NG | 1 |
Cao, YF; Chen, YR; Fang, MS; Huang, OL; Liao, ML; Wu, SC; Wu, SF; Wu, SZ; Xu, CW; Yang, XF | 1 |
Bernasconi, C | 1 |
Callís, M; Domingo Albós, A; Fernández-Sevilla, A; Juliá, A; Petit, J; Puig, J; Vilá, J; Zuazu, J | 1 |
Bagot, M; Cordonnier, C; Jais, JP; Kuentz, M; Landais, P; Oksenhendler, E; Roujeau, JC; Vernant, JP | 1 |
Cate, CC; Curphey, TJ; Douple, EB; Maurer, LH; Pettengill, OS; Sorenson, GD | 1 |
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT | 1 |
Cavelli, F; Degnan, TJ; Holland, JF; Mick, R; Silver, RT | 1 |
Brunat-Mentigny, M; Chastagner, P; Czorny, A; Lapras, C; Olive, D; Philip, T; Zucker, JM | 1 |
Phillips, GL; Reece, DE | 1 |
David, R; Douay, L; Gorin, NC; Kantor, G; Laporte, JP; Lemonnier, MP; Lopez, M; Pene, F; Stachowiak, J; van den Akker, J | 1 |
Brugerie, E; Huong, TH; Lheritier, J; Pouillart, R | 1 |
Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D | 1 |
Baehner, R; Chard, R; Hammond, D; Higgins, G; Movassaghi, N; Pyesmany, A; Sather, H | 1 |
Heim, ME; Queisser, W | 1 |
Biron, P; Dutou, L; Ehrsam, A; Hervé, P; Le Mevel, A; Philip, I; Philip, T; Philippe, N; Plouvier, E; Souillet, G | 1 |
David, R; Douay, L; Gorin, NC; Lecomte, D; Lopez, M; Najman, A; Oppenheimer, M; Parlier, Y; Salmon, C; Stachowiak, J | 1 |
Postma, DS; Wallenborn, PA | 1 |
Feinstein, DI; Forman, SJ; Koehler, SC; Levine, AM; Liebman, H; Lukes, RJ; Meyer, PR; Paganini-Hill, A; Pockros, A | 1 |
David, R; Duhamel, G; Gorin, NC; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J | 1 |
Khoo, RK; Ng, PR; Todd, D | 1 |
Edelstein, MB; Lelieveld, P; Mulder, JH; van Putten, LM | 1 |
Barrantes, JC; Barrantes, M; García, I; González, M; Jiménez, R; Lobo-Sanahuja, F | 1 |
Lin, B; Wu, D; Xia, X | 1 |
Bai, H; Da, WM; Huang, YS; Liu, Y; Ou, YX; Wang, CB; Wu, XX; Xu, SF; Zhong, JT | 1 |
McKendrick, JJ; Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
Ilveskoski, I; Lanning, M; Mäkipernaa, A; Perkkiö, M; Pihko, H; Saarinen, UM; Salmi, TT; Wiklund, T | 1 |
Bianco, AR; Biondi, E; Lauria, R; Matano, E; Montesarchio, V; Morabito, A; Pagliarulo, C; Palmieri, G; Rea, A; Tagliaferri, P | 1 |
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
Bergeron, C; Brugières, L; Delsol, G; Hartmann, O; Landmann, J; Le Deley, MC; Pacquement, H; Patte, C; Perel, Y; Quartier, P; Schmitt, C; Terrier-Lacombe, MJ | 1 |
Chizzali-Bonfadin, C; Filipits, M; Heinzl, H; Jaeger, U; Pirker, R; Simonitsch, I | 1 |
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J | 1 |
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
Southcott, BM; Stewart, AJ | 1 |
Baron, B; Bogdhan, U; Chinot, O; De Beule, N; Delattre, JY; Frenay, M; Hildebrand, J; Hoang-Xuan, K; Soubeyran, P; Taillandier, L | 1 |
Benchekroun, S; Harif, M; Qachouh, M; Quessar, A | 1 |
Apperley, J; Chaidos, A; Davis, J; Giles, C; Kanfer, EJ; Lampert, I; Loaiza, S; MacDonald, D; Marin, D; Naresh, K; O'Shea, D; Olavarria, E; Perz, JB; Rahemtulla, A; Samson, D; Sanz, J; Szydlo, R; Wagner, S | 1 |
Aguila, B; Allouche, S; Balboni, G; Borsodi, A; Boulouard, M; Coulbault, L; Davis, A; Jauzac, P; Léveillé, F; Salvadori, S; Tóth, G | 1 |
Dastugue, N; Huguet, F; Ifrah, N; Jourdan, E; Perreau, V; Pigneux, A; Reiffers, J; Salmi, LR; Sotto, JJ; Vey, N | 1 |
Apperley, J; Bower, M; Chaidos, A; Gabriel, I; Gazzard, B; Giles, C; Kanfer, E; Kew, A; Nelson, M | 1 |
Bene, MC; Berthou, C; Cahn, JY; Dreyfus, F; Escoffre-Barbe, M; Fegueux, N; Harousseau, JL; Himberlin, C; Hunault-Berger, M; Ifrah, N; Jourdan, E; Lioure, B; Lissandre, S; Luquet, I; Milpied, N; Pigneux, A; Recher, C; Reiffers, J; Sauvezie, M; Witz, F | 1 |
Apperley, JF; Auner, HW; Contento, A; Ellis, S; Giles, C; Kanfer, EJ; MacDonald, DH; Naresh, K; Pavlů, J; Rahemtulla, A; Szydlo, RM | 1 |
Appelbaum, FR | 1 |
Dehghani, M; Haghighinejad, H; Mohamadian, M; Nourani, H; Ramzi, M; Vojdani, R; Zakerinia, M | 1 |
Atalla, A; Borges dos Santos, K; Hallack Neto, AE | 1 |
Atalla, A; Costa, LJ; dos Santos, KB; Hallack-Neto, AE; Pereira, J | 1 |
Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E | 1 |
Gore, A; Gupta, A; Jain, R; Jeevangi, N; Kannan, S; Khattry, N; Nair, R; Saikia, T; Thippeswamy, R | 1 |
Ardeshna, KM; Foley, M; Kothari, J; Lambert, J; Linch, DC; Mackenzie, S; Morris, E; Peggs, KS; Thomson, K; Virchis, AE | 1 |
Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL | 1 |
Gourd, E | 1 |
Bérard, E; Bertoli, S; Delabesse, E; Huguet, F; Picard, M; Récher, C; Sarry, A; Tavitian, S; Vergez, F | 1 |
Fukui, T; Goto, M; Hakiri, S; Hashimoto, K; Ito, T; Kawaguchi, K; Mori, S; Nakamura, S; Ozeki, N; Yokoi, K | 1 |
Chen, M; Chen, X; Fang, F; Guo, J; Han, L; Hung, MC; Kuang, X; Li, H; Li, J; Liang, L; Liu, H; Liu, J; Ma, F; Peng, C; Su, J; Sun, L; Tao, J; Weng, L; Xie, Y; Xie, Z; Xu, X; Yang, N; Ye, Y; Zhang, J; Zhang, X; Zhang, Y; Zhao, S | 1 |
Kelsey, P; Kirkland, K; Lambert, J; Malladi, R; Morley, N; Paul, R; Pearce, R; Peniket, A; Perry, J; Snowden, JA | 1 |
Blackwood, L; Harper, A; Smallwood, K | 1 |
Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E | 1 |
8 review(s) available for lomustine and cytarabine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in cancer chemotherapy.
Topics: Bleomycin; Burkitt Lymphoma; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitosis; Neoplasms; Pregnancy; Skin Neoplasms; Vincristine | 1975 |
The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Asparaginase; Benzamides; Busulfan; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Erythrocytes; Fluorouracil; Hematopoietic Stem Cells; Humans; Hydroxyurea; Lomustine; Methotrexate; Nitrogen Mustard Compounds; Spleen; Vinca Alkaloids | 1976 |
Etoposide: fifteen years experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lomustine; Melphalan; Mitoxantrone | 1989 |
Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Pulmonary Fibrosis; Risk; Thioguanine; Transplantation, Autologous; Whole-Body Irradiation | 1986 |
Chemotherapy in alimentary tract malignomas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Rectal Neoplasms; Semustine; Stomach Neoplasms; Streptozocin; Tegafur; Vincristine | 1981 |
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Eruptions; Female; Humans; Hyperpigmentation; Idarubicin; Lomustine; Male; Middle Aged; Paclitaxel; Vincristine | 2015 |
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioma; Humans; Hydroxyurea; Lomustine; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Randomized Controlled Trials as Topic; Temozolomide; Vincristine | 2017 |
12 trial(s) available for lomustine and cytarabine
Article | Year |
---|---|
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Lomustine; Male; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1978 |
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Busulfan; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lomustine; Male; Middle Aged; Remission Induction; Time Factors | 1992 |
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytosine arabinoside and cis-chloronitrosurea during the course of busulfan-maintained remission.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Busulfan; Clinical Trials as Topic; Cytarabine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lomustine; Male; Middle Aged; Random Allocation; Sex Factors | 1988 |
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Humans; Lomustine; Probability; Streptozocin; Tilorone; Triazines | 1981 |
Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
Topics: Adolescent; Adult; Ancitabine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Delayed-Action Preparations; Female; Humans; Infant; Injections, Intraperitoneal; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lomustine; Male; Podophyllotoxin | 1984 |
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Hearing Loss; Humans; Hydroxyurea; Incidence; Infant; Lomustine; Male; Methylprednisolone; Procarbazine; Radiation Injuries; Risk Factors; Vincristine | 1996 |
Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Topics: Adolescent; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Interferon-alpha; Karnofsky Performance Status; Leucovorin; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1998 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biopsy, Needle; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Spinal; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Procarbazine; Research; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Survival Rate; Treatment Outcome | 2007 |
Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cryopreservation; Cytarabine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Male; Melphalan; Middle Aged; Prognosis; Recurrence; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2012 |
64 other study(ies) available for lomustine and cytarabine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[New drugs for the therapy of acute leukemia].
Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Guanazole; Humans; Leukemia; Lomustine; Peptichemio; Podophyllotoxin; Razoxane; Zinostatin | 1975 |
Pharmacokinetic studies of a transplantable murine renal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Kidney Neoplasms; Lomustine; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental | 1977 |
Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Cytarabine; Doxorubicin; Drug Resistance; Hydroxyurea; Liver Neoplasms; Lomustine; Neoplasms, Experimental; Rats; Semustine | 1978 |
Chemotherapy for lung cancer.
Topics: Bleomycin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Vinblastine; Vincristine | 1978 |
Epithelioid sarcoma: case report with ultrastructural review, histogenetic discussion, and chemotherapeutic data.
Topics: Abdominal Muscles; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Epithelial Cells; Epithelium; Female; Fluorouracil; Histiocytes; Humans; Lomustine; Middle Aged; Sarcoma; Synovial Membrane | 1976 |
Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Cells, Cultured; Culture Media; Cytarabine; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Glucose; Hydroxyurea; Kinetics; Leukemia L1210; Lomustine; Streptozocin; Thymidine; Vincristine | 1977 |
Clinical management of advanced gastrointestinal cancer.
Topics: Adenoma, Islet Cell; Carcinoma, Hepatocellular; Carmustine; Colonic Neoplasms; Cytarabine; Drug Therapy, Combination; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lomustine; Malignant Carcinoid Syndrome; Mitomycins; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Streptozocin | 1975 |
Clinical bone marrow transplantation (BMT) in children with acute lymphoblastic leukemia (ALL). Presentation of cases (Munchen group) [proceedings].
Topics: Bone Marrow Transplantation; Carmustine; Child; Cyclophosphamide; Cytarabine; Female; Graft Survival; Humans; Leukemia, Lymphoid; Lomustine; Male; Transplantation, Homologous | 1978 |
[High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Hematopoiesis; Humans; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Neoplasms; Remission, Spontaneous; Thioguanine; Transplantation, Autologous | 1978 |
Management of Burkitt's lymphoma involving the central nervous system.
Topics: Antineoplastic Agents; Brain Neoplasms; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Humans; Lomustine; Methotrexate; Nitrosourea Compounds; Spinal Cord Neoplasms; Vincristine | 1976 |
Chemotherapy of experimental meningeal carcinomatosis.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Female; Injections, Intraventricular; Lomustine; Meninges; Methotrexate; Rats; Semustine | 1977 |
[The therapy of acute myelogenous leukemia].
Topics: Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia, Myeloid, Acute; Lomustine; Thioguanine | 1975 |
Acute granulocytic leukemia: treatment of the disease.
Topics: Adolescent; Adult; Age Factors; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Infant; Leukemia, Myeloid, Acute; Lomustine; Meningitis; Middle Aged; Prognosis; Thioguanine | 1976 |
Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Stereoisomerism; Tretinoin | 1991 |
Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Feasibility Studies; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Thioguanine; Transplantation, Autologous | 1991 |
Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Remission Induction; Survival Rate | 1990 |
Acanthocytosis and acute leukaemia.
Topics: Acanthocytes; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Stimulating Factors; Cytarabine; Daunorubicin; Erythrocytes, Abnormal; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Leukemia, Monocytic, Acute; Lomustine; Male; Middle Aged | 1990 |
[Chemotherapy combined with selective resection in small cell lung cancer--analysis of 239 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality Therapy; Cytarabine; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Nitrogen Mustard Compounds; Procarbazine; Vincristine | 1986 |
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Vindesine | 1989 |
Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Prognosis; Remission Induction | 1989 |
Evaluation of drug efficacy in vitro using human small cell carcinoma of the lung spheroids.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cell Line; Cisplatin; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Mice; Mice, Inbred Strains; Peritoneum; Tumor Stem Cell Assay | 1985 |
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1987 |
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cytarabine; Cytidine Diphosphate Diglycerides; Dacarbazine; Female; Glioma; Humans; Hydroxyurea; Infant; Lomustine; Male; Medulloblastoma; Methylprednisolone; Procarbazine; Vincristine | 1988 |
Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Karyotyping; Leukemia, Myeloid; Lomustine; Male; Middle Aged; Platelet Transfusion; Thioguanine; Transplantation, Autologous | 1986 |
Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Kinetics; Leukemia L1210; Lomustine; Mathematics; Methotrexate; Mice; Mitomycins; Neoplasm Transplantation; Nitrosourea Compounds; Time Factors; Vincristine | 1974 |
Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Lomustine; Lymphoma; Male; Risk; Thioguanine; Whole-Body Irradiation | 1983 |
Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Freezing; Hematopoiesis; Humans; Lomustine; Lymphoma; Prognosis; Thioguanine; Time Factors; Transplantation, Autologous; Whole-Body Irradiation | 1984 |
Radiation recall supraglottitis. A hazard in head and neck chemotherapy.
Topics: Cytarabine; Epiglottitis; Head and Neck Neoplasms; Humans; Laryngitis; Lomustine; Lymphoma; Male; Middle Aged; Radiation Injuries | 1984 |
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
Topics: Adolescent; Adult; Asparaginase; Brain; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Injections, Spinal; Lomustine; Lymphoma; Male; Mediastinum; Methotrexate; Middle Aged; Prednisone; T-Lymphocytes; Vincristine | 1983 |
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Freezing; Hematopoiesis; Humans; Leukemia; Leukocyte Count; Lomustine; Lymphoma; Male; Middle Aged; Neoplasms; Platelet Count; Thioguanine; Transplantation, Autologous | 1981 |
Salvage chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Thrombocytopenia | 1982 |
Cell kinetic factors, single drugs and combination.
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Interactions; Fluorouracil; Humans; Kinetics; Lomustine; Methotrexate; Vincristine | 1980 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cytarabine; Epirubicin; Female; Hodgkin Disease; Humans; Laparotomy; Lomustine; Male; Methotrexate; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
[Disease-free survival of acute leukemia patients receiving autologous bone marrow transplant following intensive chemotherapy--a report of 11 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Thioguanine | 1995 |
Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Vincristine; Whole-Body Irradiation | 1993 |
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Prospective Studies; Thioguanine | 1993 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; France; Humans; Infant; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 2000 |
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Immunohistochemistry; Lomustine; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prednimustine; Prednisone; Regression Analysis; Survival Analysis; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2000 |
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53 | 2000 |
Coeliac disease following high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Diarrhea; Diet; Doxorubicin; Etoposide; Glutens; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Morbidity; Prednisolone; Vincristine | 2002 |
[Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Time Factors | 2003 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Recurrence; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Binding, Competitive; Cell Line, Tumor; Cytarabine; Depression; Desensitization, Immunologic; Disease Models, Animal; Drug Administration Schedule; Drug Tolerance; Endocytosis; Humans; Lomustine; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitoxantrone; Neuroblastoma; Oligopeptides; Phosphorylation; Prednisone; Receptors, Opioid, delta; Signal Transduction; Swimming | 2007 |
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Remission Induction; Transplantation, Autologous | 2008 |
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vomiting; Young Adult | 2011 |
Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lomustine; Nitrosourea Compounds; Treatment Outcome | 2010 |
Modified BEAM conditioning regimen in patients with Hodgkin and non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Melphalan | 2012 |
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Transplantation Conditioning; Young Adult | 2014 |
LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.
Topics: Adolescent; Adult; Autografts; Carmustine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Survival Rate; Transplantation Conditioning; Young Adult | 2016 |
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2016 |
Lomustine in older patients with acute myeloid leukaemia.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2018 |
Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukocytosis; Lomustine; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Multimodality therapy for thymoma patients with pleural dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Humans; Induction Chemotherapy; Lomustine; Male; Middle Aged; Mitoxantrone; Myasthenia Gravis; Neoplasm Recurrence, Local; Pleural Diseases; Pneumonectomy; Prednisone; Retrospective Studies; Survival Rate; Thymoma; Thymus Neoplasms | 2019 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytarabine; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Mitoxantrone; Prednisone; Receptor, Adenosine A1; Tumor Escape; Xenograft Model Antitumor Assays | 2020 |
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine; Lymphoma; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2021 |
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytarabine; Lomustine; Lymphoma; Methotrexate; Neoplasm Recurrence, Local | 2021 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lomustine; Lymphoma; Methotrexate; Middle Aged; Procarbazine; Receptors, Thrombopoietin; Rituximab | 2022 |